Understanding the relationship between the primary structure of proteins and their amyloidogenic propensity: clues from inclusion body formation.
暂无分享,去创建一个
[1] R. Wetzel. Mutations and off-pathway aggregation of proteins. , 1994, Trends in biotechnology.
[2] J. Torres,et al. Conformational Switching and Fibrillogenesis in the Amyloidogenic Fragment of Apolipoprotein A-I* , 2003, The Journal of Biological Chemistry.
[3] F. Cohen,et al. Theoretical studies of sequence effects on the conformational properties of a fragment of the prion protein: implications for scrapie formation. , 1995, Chemistry & biology.
[4] D. Kirschner,et al. X-ray diffraction analysis of scrapie prion: intermediate and folded structures in a peptide containing two putative alpha-helices. , 1997, Journal of molecular biology.
[5] Alan R. Fersht,et al. Capping and α-helix stability , 1989, Nature.
[6] Todd M. Przybycien,et al. Secondary structure characterization of beta-lactamase inclusion bodies. , 1994, Protein engineering.
[7] W. Kabsch,et al. Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.
[8] R. Nussinov,et al. The sequence dependence of fiber organization. A comparative molecular dynamics study of the islet amyloid polypeptide segments 22-27 and 22-29. , 2003, Journal of molecular biology.
[9] L Serrano,et al. Protein engineering as a strategy to avoid formation of amyloid fibrils , 2000, Protein science : a publication of the Protein Society.
[10] V. Uversky,et al. Why are “natively unfolded” proteins unstructured under physiologic conditions? , 2000, Proteins.
[11] G. Dale,et al. Improving protein solubility through rationally designed amino acid replacements: solubilization of the trimethoprim-resistant type S1 dihydrofolate reductase. , 1994, Protein engineering.
[12] L. Tjernberg,et al. Charge Attraction and β Propensity Are Necessary for Amyloid Fibril Formation from Tetrapeptides* , 2002, The Journal of Biological Chemistry.
[13] C. Dobson. Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.
[14] V. Uversky,et al. Protein folding revisited. A polypeptide chain at the folding – misfolding – nonfolding cross-roads: which way to go? , 2003, Cellular and Molecular Life Sciences CMLS.
[15] C. Dobson,et al. Rationalization of the effects of mutations on peptide andprotein aggregation rates , 2003, Nature.
[16] Michele Vendruscolo,et al. Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. , 2004, Journal of molecular biology.
[17] R J Fletterick,et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[18] A. Fink. Protein aggregation: folding aggregates, inclusion bodies and amyloid. , 1998, Folding & design.
[19] P. Tompa. Intrinsically unstructured proteins. , 2002, Trends in biochemical sciences.
[20] Susan Jones,et al. Amyloid-forming peptides from beta2-microglobulin-Insights into the mechanism of fibril formation in vitro. , 2003, Journal of molecular biology.
[21] Ž. Eva. Amyloid-fibril formation: Proposed mechanisms and relevance to conformational disease , 2002 .
[22] G. Olsen,et al. Thermal adaptation analyzed by comparison of protein sequences from mesophilic and extremely thermophilic Methanococcus species. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[23] Eliora Z Ron,et al. Protein aggregation in Escherichia coli: role of proteases. , 2002, FEMS microbiology letters.
[24] Christopher M. Dobson,et al. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis , 1997, Nature.
[25] U Aebi,et al. Amyloid fibril formation from full-length and fragments of amylin. , 2000, Journal of structural biology.
[26] M. Franceschi,et al. Protein misfolding in Alzheimer’s and Parkinson’s disease: genetics and molecular mechanisms , 2002, Neurobiology of Aging.
[27] J. King,et al. Thermolabile folding intermediates: inclusion body precursors and chaperonin substrates , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] M. Baumann,et al. Amphoterin includes a sequence motif which is homologous to the Alzheimer's beta-amyloid peptide (Abeta), forms amyloid fibrils in vitro, and binds avidly to Abeta. , 2001, Biochemistry.
[29] A. Doig,et al. Effect of the N3 residue on the stability of the α‐helix , 2004 .
[30] Y. Kallberg,et al. Prediction of Amyloid Fibril-forming Proteins* , 2001, The Journal of Biological Chemistry.
[31] Fabrizio Chiti,et al. The regions of the sequence most exposed to the solvent within the amyloidogenic state of a protein initiate the aggregation process. , 2004, Journal of molecular biology.
[32] C. Soto,et al. The -Helical to -Strand Transition in the Amino-terminal Fragment of the Amyloid -Peptide Modulates Amyloid Formation * , 1995, The Journal of Biological Chemistry.
[33] D. Thirumalai,et al. Emerging ideas on the molecular basis of protein and peptide aggregation. , 2003, Current opinion in structural biology.
[34] E. Berger,et al. Improving solubility of catalytic domain of human beta-1,4-galactosyltransferase 1 through rationally designed amino acid replacements. , 2001, European journal of biochemistry.
[35] M. W. Pandit,et al. Correlation between stability of a protein and its dipeptide composition: a novel approach for predicting in vivo stability of a protein from its primary sequence. , 1990, Protein engineering.